Propanc Biopharma (PPCB) Q1 2026 Earnings

Screener

Reported May 14, 2026 · Before market open

EPS-$0.28

Next report

Date not yet announced

Versus estimates

Revenue

Diluted EPS

Q1 2026-$0.28

Q4 2025-$0.30 Q3 2025-$0.39 Q2 2025-$0.35 Q1 2025-$12.50 Q4 2024-$32.23

FAQ

When did Propanc Biopharma report Q1 2026 earnings?: Propanc Biopharma (PPCB) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Propanc Biopharma's Q1 2026 revenue and EPS?: Propanc Biopharma reported eps of $-0.28 for Q1 2026.
How did Propanc Biopharma's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, eps grew 97.8% from $-12.50.
Where can I find Propanc Biopharma's Q1 2026 SEC filings?: You can read the 10-Q periodic report (0001493152-26-023210) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Propanc Biopharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk